Top 10 Value Stocks To Invest In Right Now


HubSpot (NYSE:HUBS) had its price objective upped by investment analysts at Stifel Nicolaus from $110.00 to $115.00 in a research note issued to investors on Monday. The firm presently has a “buy” rating on the software maker’s stock. Stifel Nicolaus’ price target would indicate a potential upside of 4.50% from the company’s current price.

A number of other research analysts have also recently commented on the stock. UBS increased their target price on shares of HubSpot from $103.00 to $105.00 and gave the stock an “outperform” rating in a report on Wednesday, February 14th. Needham & Company LLC increased their target price on shares of HubSpot from $95.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, February 14th. Canaccord Genuity increased their target price on shares of HubSpot from $98.00 to $115.00 and gave the stock a “buy” rating in a report on Wednesday, February 14th. Morgan Stanley reissued an “equal weight” rating and issued a $96.00 target price (down previously from $99.00) on shares of HubSpot in a report on Tuesday, January 30th. They noted that the move was a valuation call. Finally, ValuEngine raised shares of HubSpot from a “hold” rating to a “buy” rating in a report on Monday, April 2nd. Seven analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $105.50.

Top 10 Value Stocks To Invest In Right Now: Clearside BioMedical, Inc. (CLSD)


Advisors’ Opinion:

  • [By Keith Noonan]

    Clearside Biomedical, Inc. Stock (NASDAQ:CLSD)stock rose 66.1% in March, according to data provided byS&P Global Market Intelligence.

Top 10 Value Stocks To Invest In Right Now: Embraer-Empresa Brasileira de Aeronautica(ERJ)

Advisors’ Opinion:

  • [By Paul Ausick]

    Boeing also confirmed on Thursday that it has discussed a “possible combination” with Brazil’s Embraer S.A. (NYSE: ERJ), a response to the deal Bombardier struck with Airbus in which the European company took control of Bombardier’s C Series program. A deal between Boeing and Embraer is no sure thing, mainly because the Brazilian government holds a controlling interest in Embraer.

  • [By Adam Levine-Weinberg]

    Shares of Brazilian aerospace company Embraer (NYSE:ERJ) surged in late 2017 after Boeing (NYSE:BA) confirmed its interest in buying its smaller rival. However, Embraer stock has retreated in recent weeks, based on reports that negotiators for the two companies are having trouble agreeing on the finer points of a deal.

  • [By Paul Ausick]

    Finally, CEO Dennis Muilenburg said Thursday that the company is nearing an agreement with Brazil’s Embraer S.A. (NYSE: ERJ) that would give Boeing a controlling stake in Embraer’s commercial jet business and leave the firm’s military business under Brazilian government control.

  • [By Dan Caplinger]

    Aircraft manufacturers have been some of the biggest beneficiaries of the resurgence of airline stocks, and for Brazil’s Embraer (NYSE:ERJ), a focus on smaller aircraft that airlines can use to fill in route maps has paid off with strong results. Yet even with favorable overall conditions for the industry, Embraer has seen ups and downs from quarter to quarter, sometimes having to endure setbacks along the way.

Top 10 Value Stocks To Invest In Right Now: Dermira, Inc.(DERM)


Advisors’ Opinion:

  • [By Chris Lange]

    Dermira Inc. (NASDAQ: DERM) watched its shares absolutely collapse early on Monday after the firm reported disappointing results from its late-stage trials in patients with acne vulgaris. Essentially, Dermiras Phase 3 trials of the investigational treatment olumacostat glasaretil (formerly DRM01) did not meet the co-primary endpoints.

  • [By Paul Ausick]

    Dermira Inc. (NASDAQ: DERM) traded down about 64% Monday and posted a new 52-week low of $8.95 after closing Friday at $25.16. The stock’s 52-week high is $38.39. Volume was about 40 times the daily average of around 615,000 shares. The company’s trial of a new acne treatment failed to meet the designated endpoints.

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

Top 10 Value Stocks To Invest In Right Now: News Corporation(NWS)


Advisors’ Opinion:

  • [By Joseph Griffin]

    New Media Inv Group (NYSE: NEWM) and News (NASDAQ:NWS) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

Top 10 Value Stocks To Invest In Right Now: OGE Energy Corporation(OGE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on OGE Energy (OGE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks To Invest In Right Now: Denbury Resources Inc.(DNR)

Advisors’ Opinion:

  • [By VantagePoint]

    Denbury Resources Inc. (NYSE: DNR) follows the same idea but to the upside. That market had a bullish crossover in early-April. Traders knew, with confidence, that they could begin going long in the market when the predictive indicators in VantagePoint showed that crossover to the upside. Since that crossover of the blue line 24 trading days ago, the market was up over 36 percent or $1.01 per share.

  • [By Logan Wallace]

    TRADEMARK VIOLATION WARNING: “Denbury Resources (DNR) Bonds Rise 1.8% During Trading Insider Trade” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at www.tickerreport.com/banking-finance/3352072/denbury-resources-dnr-bonds-rise-1-8-during-trading-insider-trade.html.

  • [By Matthew DiLallo]

    That bullish inventory number, along with the potential for even higher oil prices, sent oil stocks soaring, with several smaller producers spiking more than 10% today. Among that group was EP Energy (NYSE:EPE), Sanchez Energy (NYSE:SN), Denbury Resources (NYSE:DNR), HighPoint Resources (NYSE:HPR), and Carrizo Oil & Gas (NASDAQ:CRZO).

  • [By Lisa Levin] Companies Reporting Before The Bell
    Celgene Corporation (NASDAQ: CELG) is projected to report quarterly earnings at $1.96 per share on revenue of $3.46 billion.
    Aon plc (NYSE: AON) is expected to report quarterly earnings at $2.8 per share on revenue of $2.93 billion.
    American Axle & Manufacturing Holdings, Inc. (NYSE: AXL) is estimated to report quarterly earnings at $0.81 per share on revenue of $1.75 billion.
    Alibaba Group Holding Limited (NYSE: BABA) is expected to report quarterly earnings at $0.88 per share on revenue of $9.27 billion.
    LifePoint Health, Inc. (NASDAQ: LPNT) is projected to report quarterly earnings at $1.13 per share on revenue of $1.62 billion.
    V.F. Corporation (NYSE: VFC) is estimated to report quarterly earnings at $0.65 per share on revenue of $2.90 billion.
    Newell Brands Inc. (NYSE: NWL) is expected to report quarterly earnings at $0.26 per share on revenue of $3.05 billion.
    Titan International, Inc. (NYSE: TWI) is projected to report quarterly earnings at $0.04 per share on revenue of $407.27 million.
    Boise Cascade Company (NYSE: BCC) is expected to report quarterly earnings at $0.45 per share on revenue of $1.09 billion.
    Cheniere Energy, Inc. (NYSE: LNG) is estimated to report quarterly earnings at $0.39 per share on revenue of $1.59 billion.
    Cboe Global Markets, Inc. (NASDAQ: CBOE) is projected to report quarterly earnings at $1.24 per share on revenue of $308.05 million.
    ITT Inc. (NYSE: ITT) is estimated to report quarterly earnings at $0.73 per share on revenue of $683.96 million.
    Fred's, Inc. (NASDAQ: FRED) is expected to report quarterly loss at $0.19 per share on revenue of $551.00 million.
    Virtu Financial, Inc. (NASDAQ: VIRT) is projected to report quarterly earnings at $0.52 per share on revenue of $288.31 million.
    Cheniere Energy Partners, L.P. (NYSE: CQP) is expected to report quarterly earnings at $0.57 per share on revenue of $1.38 billion.
    Genesis Energy, L.P

Top 10 Value Stocks To Invest In Right Now: AVEO Pharmaceuticals, Inc.(AVEO)


Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of AVEO Pharmaceuticals (NASDAQ:AVEO) fell 17% today after the company announced first-quarter 2018 results and provided a business update. As a development stage biopharma company, there’s wasn’t much in the way of new financial details. However, the company did announce that it was delaying the expected readout of top-line data from the ongoing phase 3 trial of its lead drug candidate from the second quarter of 2018 to the third quarter of 2018.

Top 10 Value Stocks To Invest In Right Now: First Capital Bancorp Inc.(VA)


Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows JetBlue Airways Corporation giving a good performance thats still not as good as that of large cap Southwest Airlines Co (NYSE: LUV) while the performance ofAlaska Air Group, Inc (NYSE: ALK), which has acquired Virgin America Inc (NASDAQ: VA), seems to have slipped recently:

Top 10 Value Stocks To Invest In Right Now: Sorrento Therapeutics, Inc.(SRNE)

Advisors’ Opinion:

  • [By William Romov]

    San Diego-based Sorrento Therapeutics Inc. (Nasdaq: SRNE) develops drugs to treat certain types of cancer and chronic cancer pain.

    On Jan. 6, company officials will present a new proprietary technology for the treatment of cancer. Analysts are calling this new technology a potential “game-changer.”

  • [By ]

    Sorrento Therapeutics (SRNE) : “This is the kind of speculative stock that I like.”

    Geron (GERN) : “Let’s stick with high quality like Thermo Fisher Scientific (TMO) .”

  • [By ]

    In the Lightning Round, Cramer was bullish on Spotify (SPOT) , Alkermes (ALKS) , Johnson & Johnson (JNJ) , Thermo Fisher Scientific (TMO) , Sorrento Therapeutics (SRNE) , NVIDIA (NVDA) , Nucor, Eli Lilly (LLY) and Kohlberg Kravis Roberts (KKR) .

Top 10 Value Stocks To Invest In Right Now: U.S. Bancorp(USB)

Advisors’ Opinion:

  • [By ]

    Selected examples: (BXP) , (DFS) , (HST) , (MA) , (TXN) , (USB) .

    Inflation Is a Key Risk

    Execs were most worried about inflation, as they should be.

  • [By John Maxfield]

    Lapera: [laughs] In that case,now that we’re done with this small talk, let’s talk aboutPNC Bankandshareholder letters. We’re going to interweave the two topics. Let’s start with what’s going on with PNC Bank in general right now. Thereason we picked PNC Bank to begin with is becauseafter doing that [U.S. Bancorp] (NYSE: USB) episode last week, which,if you want to link to that, I’m happy to send it. Maxfield finally published that article onthe Richard Davis interview. If you emailed me about that,I’m going to email you back as soon as the show is over and send that to you. Ifanyone else wants that article,I’m more than happy to email it to you. Our email is industryfocus@fool.com. Winding back,the reason we’re talking about PNC Bank isbecause we talked about how great U.S. Bancorp’sefficiency ratio is, and PNC Bank has aneven better one.

  • [By Jordan Wathen, Matthew Frankel, and Dan Caplinger]

    But investors can do even better by selecting the very best banks the market has to offer. Below, three Fool.com contributors make the case for whyBB&T Corporation (NYSE:BBT), US Bancorp (NYSE:USB), and Goldman Sachs (NYSE:GS)are worthy additions to your portfolio.

Leave a Reply

Your email address will not be published. Required fields are marked *